ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors

Laura Solé; Eric Cantón; María Maqueda; Teresa Lobo‐Jarne; Antonio Barbáchano; Ferràn Torres; Júlia-Jié Cabré-Romans; Ángela Montoto; Lierni Fernández‐Ibarrondo; D. Martínez‐García; Marta Guix; Mónica Larrubia-Loring; Clara Montagut; Alberto Múñoz; Anna Bigas; Mar Iglesias; Beatríz Bellosillo; Lluı́s Espinosa

doi:10.1038/s41416-025-03280-2

Abstract

Our results reveal ColoStem and EpiColoStem tests as valuable tools for refining patient prognosis through the identification of fetal-type CRC tumors.

Affiliated Institutions

Related Publications

Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society

Samuel J. LaMonte , Ruth Etzioni , Matthew T. McKenna +16 more

Abstract In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guidel...

2018 CA A Cancer Journal for Clinicians 1945 citations

Hereditary Colorectal Cancer

Henry T. Lynch , Albert de la Chapelle

The question, "Is cancer hereditary?" has been answered beyond any doubt through the discovery of germ-line cancer-causing mutations in a subset of colorectal cancers (CRCs). Cl...

2003 New England Journal of Medicine 2165 citations

Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts

John Hodgson , Ru-Fang Yeh , Amrita Ray +11 more

Development of model systems that recapitulate the molecular heterogeneity observed among glioblastoma multiforme (GBM) tumors will expedite the testing of targeted molecular th...

2009 Neuro-Oncology 151 citations

Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study

Yanbin Chen , Chuanyong Mu , Jian‐An Huang

Aims and background The programmed death-1-ligand 1 (PD-L1) has been recently suggested to play a pivotal role in the immune evasion of tumors from host immune system. In the st...

2012 Tumori Journal 216 citations

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

Richard W. Tothill , Anna V. Tinker , Joshy George +15 more

Abstract Purpose: The study aim to identify novel molecular subtypes of ovarian cancer by gene expression profiling with linkage to clinical and pathologic features. Experimenta...

2008 Clinical Cancer Research 1472 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Influential

Cite This

APA Style

                            
                                    Laura Solé, 
                                
                                    Eric Cantón, 
                                
                                    María Maqueda
                                
                                et al.
                            
                            (2025). 
                            ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors. 
                            British Journal of Cancer
                            
                            .
                            https://doi.org/10.1038/s41416-025-03280-2

Identifiers

DOI: 10.1038/s41416-025-03280-2
PMID: 41372484

Data Quality

Data completeness: 77%